HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Ulf W. Kjellman Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kjellman, U. W. Articles by Wernerman, J. Search for Related Content PubMed PubMed Citation Articles by Kjellman, U. W. Articles by Wernerman, J. Related Collections Related Article

Ann Thorac Surg 1997;63:1625-1633
© 1997 The Society of Thoracic Surgeons

---

Original Article: Cardiovascular

Addition of -Ketoglutarate to Blood Cardioplegia Improves Cardioprotection

Department of Thoracic and Cardiovascular Surgery, Sahlgrenska University Hospital, Göteborg, and Department of Anesthesiology, Huddinge Hospital, Stockholm, Sweden

Accepted for publication November 12, 1996.

Background. We hypothesized that myocardial content of -ketoglutarate (-KG), an intermediate of the Krebs cycle, can be critically low during heart operations, and that provision of -KG could reduce metabolic abnormalities and lead to improved myocardial protection.

Methods. Twenty-four men aged 46 to 78 years who were undergoing heart operations participated in a prospective, controlled, randomized study. In 13 patients, an average of 28 g of -KG was added to blood cardioplegia. Plasma creatine kinase isoenzyme MB and troponin T, and myocardial extraction of oxygen, substrates, and amino acids were measured.

Results. -Ketoglutarate treatment was associated with lower creatine kinase isoenzyme MB (F = 39.6, df = 1.172, p < 0.001) and lower troponin (F = 12.9, df = 1.172, p < 0.001). The values at 4 hours were 31 ± 2.4 µg/L versus 49 ± 4.9 µg/L (creatine kinase isoenzyme MB) and 1.1 ± 0.05 µg/L versus 2.0 ± 0.34 µg/L (troponin T). Myocardial oxygen extraction was higher during -KG cardioplegia (p < 0.01), but there were no significant differences in myocardial uptake or release of substrates or amino acids. Lactate release was observed in both groups during cardioplegia. Myocardial lactate release had ceased after 30 minutes of reperfusion in nearly half the -KG–treated patients (6 of 13) but remained in all the control patients (11 of 11, p = 0.016). There were no other differences after 30 minutes of reperfusion.

Conclusion. Provision of -KG during blood cardioplegia improves myocardial protection in patients undergoing coronary operations. This may be linked to enhanced oxidation.

Related Article

Invited Commentary

Bradley S. Allen
Ann. Thorac. Surg. 1997 63: 1634. [Extract] [Full Text]

This article has been cited by other articles:

				C. Kennergren, V. Mantovani, L. Strindberg, E. Berglin, A. Hamberger, and P. Lonnroth Myocardial interstitial glucose and lactate before, during, and after cardioplegic heart arrest Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E788 - E794. [Abstract] [Full Text] [PDF]

				M. D. Crittenden Intraoperative metabolic monitoring of the heart: I. Clinical assessment of coronary sinus metabolites Ann. Thorac. Surg., December 1, 2001; 72(6): S2220 - 2226. [Abstract] [Full Text] [PDF]

				A. Jeppsson, R. Ekroth, P. Friberg, K. Kirno, I. Milocco, F. N. Nilsson, S. Svensson, and J. Wernerman Renal Effects of {alpha}-Ketoglutarate Early After Coronary Operations Ann. Thorac. Surg., March 1, 1998; 65(3): 684 - 690. [Abstract] [Full Text]